Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Risk of lower extremity complications with GLP-1 receptor agonists, SGLT2 inhibitors, and DPP-4 inhibitors in peripheral artery disease

Diabetes Research and Clinical Practice(2025)10.1016/j.diabres.2025.112982Source: DataRank Database

Risk of lower extremity complications with GLP-1 receptor agonists, SGLT2 inhibitors, and DPP-4 inhibitors in peripheral artery disease is a research paper published in Diabetes Research and Clinical Practice (2025). On theSindex it has a DataRank of 0.345. It has been cited 9 times.

N/A

0.345DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 10.00)OA: hybridTopics (42)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.345

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (7)

Forest Lin ORCID,Ivan Y. Luu ORCID,Laura Shin,Sukgu M. Han ORCID,David G. Armstrong ORCID

Live enrichment

PubMed:41177308 PMC:PMC12645714 OpenAlex:https://openalex.org/W4415756627

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: 1K23DK122126

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: 1R03DK140420

NIDDK NIH HHS

Grant: K23 DK122126

NIDDK NIH HHS

Grant: R03 DK140420

FWCI

10.00

Citation Percentile

1.0%

Citation Trend

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://www.diabetesresearchclinicalpractice.com/article/S0168-8227(25)00996-9/pdf

publisherhttps://www.diabetesresearchclinicalpractice.com/article/S0168-8227(25)00996-9/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0168822725009969?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0168822725009969?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.diabres.2025.112982

Fields of Study

Peripheral Artery Disease ManagementDiabetes Treatment and ManagementBariatric Surgery and OutcomesHumansMaleFemaleMiddle AgedDipeptidyl-Peptidase IV InhibitorsSodium-Glucose Transporter 2 InhibitorsPeripheral Arterial DiseaseGlucagon-Like Peptide-1 ReceptorDiabetes Mellitus, Type 2Amputation, SurgicalHypoglycemic Agents

MeSH Terms

Glucagon-Like Peptide-1 ReceptorSodium-Glucose Transporter 2 InhibitorsGlucagon-Like Peptide-1 Receptor AgonistsAgedAmputation, SurgicalDiabetes Mellitus, Type 2FemaleHumansHypoglycemic AgentsMaleMiddle AgedRetrospective StudiesLower ExtremityDipeptidyl-Peptidase IV InhibitorsPeripheral Arterial Disease

Keywords

Diabetes mellitusArterial diseaseComplicationVascular diseaseProspective cohort studyPeripheralDiseaseLower limbPeripheral Artery DiseaseDipeptidyl Peptidase-4 InhibitorsLimb AmputationGlucagon-like Peptide-1 Receptor AgonistsSodium-glucose Cotransporter-2 Inhibitors